| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0306 |
| Document Type: 4/A |
| Period of Report: 3/15/20 |
| Date of Original Submission: 3/17/20 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1080709 |
| Issuer Name: ARENA PHARMACEUTICALS INC |
| Issuer Trading Symbol: ARNA |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1805334 |
| | Owner Name: Schmidt Joan |
| Reporting Owner Address: |
| | Owner Street 1: C/O ARENA PHARMACEUTICALS, INC. |
| | Owner Street 2: 6154 NANCY RIDGE DRIVE |
| | Owner City: SAN DIEGO |
| | Owner State: CA |
| | Owner ZIP Code: 92121 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: EVP, General Counsel & Sec |
| Derivative Table: |
| Derivative Transaction: |
| | Security Title: |
| | | Value: Employee Stock Option (right to buy) |
| | Conversion or Exercise Price: |
| | | Value: 41.25 |
| | Transaction Date: |
| | | Value: 3/15/20 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 132,000 |
| | | Transaction Price Per Share: |
| Value: 0.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Exercise Date: |
| | | Footnote ID: F1 |
| | Expiration Date: |
| | | Value: 3/15/27 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Stock |
| | | Underlying Security Shares: |
| Value: 132,000 |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 132,000 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: The options vest over four years, with 25% of the shares subject to the option vesting on March 15, 2021, and the remainder of the shares vesting monthly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested. |
| Remarks: On March 17, 2020, the reporting person filed a Form 4 which inadvertently reported an incorrect Employee Stock Option exercise price of $36.33. In fact, as reported in this amendment, the exercise price applicable to the Employee Stock Options is $41.25. |
| Owner Signature: |
| Signature Name: /s/ Andrew J. Cronauer, as Attorney-in-Fact |
| Signature Date: 3/18/20 |
